ACGME-I Neurosurgery Residency Programme
Hamad Medical Corporation
Doha · Qatar
Listed lead Sirajeddin Belkhair (Programme Director); Abdulnasser Thabet (Associate Programme Director)
- Duration
- 7 years
- Deadline
- HMC-wide 2027–28 residency intake (opened): Category A (Qatari) 1–12 Nov 2026; Category B (non-Qatari Qatar-school graduates/children of Qatari mothers) 11–25 Dec 2026; Categories C and D 19 Jan–6 Feb 2027 (11:59 pm Qatar time). Seat inventories are posted 10 Dec 2026 and 18 Jan 2027.
- Funding
- Employment and resident benefits are governed by HMC; no fellowship-specific funding is claimed here.
- Exposure
- Adult and paediatric neurosurgery, neuroradiology, neuro-oncology, intensive care, spine, cerebrovascular and skull-base rotations across HMC and Sidra Medicine.
Source & missing information (7)
Funding: Employment and resident benefits are governed by HMC; no fellowship-specific funding is claimed here.
Exposure: Adult and paediatric neurosurgery, neuroradiology, neuro-oncology, intensive care, spine, cerebrovascular and skull-base rotations across HMC and Sidra Medicine.
Eligibility: HMC-wide: non-Qatari international medical graduates are eligible only in Category D, which requires a valid Qatar Residence Permit (plus Arabic proficiency and a recognised internship); Category B covers non-Qatari graduates of Qatar-based schools (international graduates within the past 6 years) and children of Qatari mothers; Category C is the Palestinian Amiri Scholarship.
Still to confirm: Current status · Participation level · Visa / work authorisation · Benefits · Fees · Insurance · Accommodation
Source: Official Hamad Medical Corporation programme page. Reviewed 8 Oct 2026. Status reflects the last review, not a live vacancy check. Completeness is not a quality rating.